Evidence-based ibrutinib-related adverse reactions and pharmaceutical care
LI Yanming, ZHAO Zhigang
Chinese Journal of Pharmacovigilance . 2022, (7): 807 -811 .  DOI: 10.19803/j.1672-8629.2022.07.26